Merestinib (LY2801653)

Merestinib · Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Merestinib (LY2801653), covering 2016-08-29 to 2016-08-29. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Merestinib (LY2801653) in Healthy Participants [Phase 1]